Sources: 1BitterDB, 4ClinicalTrials, 7Cochrane Library, 10DGIdb, 14DrugBank, 29HMDB, 33IUPHAR, 46NDF-RT, 50Novoseek, 56PharmGKB, 68UMLSSee all MalaCards sources |
Drugs for Premature Menopause (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 186)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Doxorubicin | approved, investigational | Phase 4, Phase 3 | 1751 | 23214-92-8 | 31703 | (1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione 111266-55-8 14-Hydroxydaunomycin 14-Hydroxydaunorubicine 14-hydroxydaunomycin 14-hydroxydaunorubicine 23214-92-8 23257-17-2 24385-08-8 25311-50-6 25316-40-9 25316-40-9 (hydrochloride) 29042-30-6 AC1L1M5T AC1Q29OJ ADM ADR Adriablastin Adriacin (hydrochloride salt) Adriamycin Adriamycin PFS Adriamycin PFS (hydrochloride salt) Adriamycin RDF Adriamycin RDF (hydrochloride salt) Adriamycin Semiquinone Adriamycin semiquinone Adriblas tina Adriblastin Adriblastina Adriblastina (TN) Adriblastina (hydrochloride salt) Aerosolized Doxorubicin BPBio1_000502 BRD-K92093830-003-04-3 BSPBio_000456 BSPBio_001031 C01661 C27H29NO11 CCRIS 739 CHEBI:28748 CHEMBL179 CID31703 Caelyx Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74 Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120 D03899 DB00997 DM2 DOX-SL Doxil Doxo Doxorubicin Doxorubicin (USAN/INN) Doxorubicin HCl | Doxorubicin Hydrochloride Doxorubicin [USAN:INN:BAN] Doxorubicin citrate Doxorubicin hydrochloride (hydrochloride salt) Doxorubicin-P4/D10 Doxorubicin-P4/D10 conjugate Doxorubicin-hLL1 Doxorubicin-hLL1 conjugate Doxorubicina Doxorubicina [INN-Spanish] Doxorubicine Doxorubicine [INN-French] Doxorubicinum Doxorubicinum [INN-Latin] EINECS 245-495-6 FI 106 Farmablastina (hydrochloride salt) HMS2089H06 HSDB 3070 Hydroxydaunomycin hydrochlor ide (hydrochloride salt) Hydroxydaunomycin hydrochloride (hydrochloride salt) Hydroxydaunorubicin Hydroxydaunorubicin hydrochloride (hydrochloride salt) JT9100000 LMPK13050001 LS-1029 LS-165655 MLS000759533 Myocet NCI-C01514 NChemBio.2007.10-comp13 NDC 38242-874 NIOSH/JT9100000 NSC 123127 Prestwick0_000438 Prestwick1_000438 Prestwick2_000438 Prestwick3_000438 Probes1_000151 Probes2_000129 RDF Rubex Resmycin Rubex Rubex (hydrochloride salt) SMP1_000106 SPBio_002395 TLC D-99 ThermoDox Triferric doxorubicin UNII-80168379AG adiblastine (hydrochloride salt) adr iablatina (hydrochloride salt) adriablastine (hydrochloride salt) adriablatina (hydrochloride salt) adriblatina (hydrochloride salt) doxorubicin nchembio809-comp5 |
| | 2 | | Progesterone | approved, vet_approved | Phase 4, Phase 3, Phase 2, Early Phase 1 | 559 | 57-83-0 | 5994 | (S)-4-Pregnene-3,20-dione (S)-Pregn-4-en-3,20-dione (S)-Progesterone .beta.-Progesterone .delta.(sup4)-Pregnene-3,20-dione .delta.4-Pregnene-3,20-dione 17.alpha.-Progesterone 17a-Progesterone 17alpha-Progesterone 17alpha-progesterone 17α-progesterone 1dbb 1h60 257630-50-5 3,20-Pregnene-4 32104FB6-BF81-4F6E-83C2-024DEEAEB272 4-Pregnen-3,20-dione 4-Pregnene-3,20-dione 46665_FLUKA 46665_RIEDEL 57-83-0 753497-20-0 8012-32-6 8023-13-0 AC-700 AC1L1LKF AI3-51682 Agolutin Akrolutin BB_NC-0185 BHR-100 BIDD:ER0547 BIDD:PXR0094 BPBio1_000676 BRD-K64994968-001-03-6 BSPBio_000614 Bio-luton C00410 CCRIS 533 CHEBI:17026 CHEMBL103 CID5994 CIDR CMC_13406 COL-1620 CPD000058345 Colprosterone Corlutin Corlutina Corluvite Corporin Corpus Luteum Hormone Corpus luteum hormone Crinone Crinone (TN) Crinone progesterone gel Curretab Cyclogest Cyclogesterin D00066 D4-Pregnene-3,20-dione DB00396 DR-2011 Delalutin Delta(4)-pregnene-3,20-dione Duraprogen EINECS 200-350-6 ETI-411 EU-0100895 Endometrin Estima FE-999913 Flavolutan Fologenon Gelbkoerperhormon Gesterol Gesterol 100 Gesterol 50 Gestiron Gestone Gestormone Gestron Glanducorpin Gynlutin Gynoluton Gynolutone HMS1569O16 HMS2051O05 HMS2090J07 HSDB 3389 Hormoflaveine Hormoluton Hydroxyprogesterone Caproate Hydroxyprogesterone Caproic acid LMST02030159 LS-234 Lingusorbs Lipo-Lutin Lipolutin Lopac0_000895 Lucorteum Lucorteum Sol Lucorteum sol Lugesteron Luteal hormone Luteinique Luteocrin normale Luteodyn Luteogan Luteohormone Luteol Luteol (VAN) Luteopur Luteosan Luteostab Luteovis Luteum Lutex Lutidon Lutin Lutinus Lutociclina Lutocuclin M Lutocyclin Lutocyclin M | Lutocyclin m Lutocylin Lutocylol Lutoform Lutogyl Lutogynon Lutren Lutromone MLS000028517 MLS000758277 MLS001074187 MLS002222367 MPA Membrettes Methylpregnone Micronized Progesterone MolPort-001-794-643 NCGC00022185-03 NCGC00022185-04 NCGC00022185-05 NCGC00022185-06 NCGC00022185-07 NCGC00022185-08 NCGC00022185-09 NCGC00090798-01 NCGC00090798-02 NCI60_042166 NSC 64377 NSC 9704 NSC-9704 NSC64377 NSC9704 Nalutron Natural Progesterone P 0130 P0130_SIGMA P0478 P3972_SIGMA P6149_SIGMA P7556_ALDRICH P7556_SIGMA P8783_SIGMA P9776_SIGMA PROGESTERONE Percutacrine Percutacrine Luteinique Piaponon Pranone Pregn-4-en-3,20-dione Pregn-4-ene-3,20-dione Pregnene-3,20-dione Pregnenedione Prestwick0_000477 Prestwick1_000477 Prestwick2_000477 Prestwick3_000477 Prestwick_411 Primolut Prochieve Progeffik Progekan Progestan Progestasert Progesterol Progesteron Progesterona Progesterona [INN-Spanish] Progesterone Progesterone (JP15/USP/INN) Progesterone [INN:BAN:JAN] Progesterone [Progestins] Progesterone, water-soluble Progesterone-Water Soluble Progesterone: HBC complex Progesteronum Progesteronum [INN-Latin] Progestin Progestogel Progestol Progeston Progestone Progestosol Progestrel Progestron Progestronol Progestérone Projestaject Prolets Prolidon Prolutin Proluton Prolutone Prometrium Prometrium (TN) Prontogest Protormone S00293 S1705_Selleck SAM001247039 SMR000058345 SMR000653542 SPBio_002553 SR-01000000088 SR-01000000088-5 Spectrum5_002053 Syngesterone Syngestrets Synovex S Syntolutan U 3672 UNII-4G7DS2Q64Y Utrogest Utrogestan Vitarrine WLN: L E5 B666 OV MUTJ A1 E1 FV1 ZINC04428529 beta-Progesterone bmse000482 component of Cyclogesterin corpus luteum hormone delta(4)-Pregnene-3,20-dione delta(Sup 4)-Pregnene-3,20-dione delta(Sup4)-pregnene-3,20-dione delta(sup 4)-Pregnene-3,20-dione delta4-Pregnene-3,20-dione luteohormone nchembio.2007.53-comp14 |
| | 3 | | Cyclophosphamide | approved, investigational | Phase 4, Phase 3, Phase 2 | 2935 | 50-18-0, 6055-19-2 | 2907 | (+-)-Cyclophosphamide (-)-Cyclophosphamide (RS)-Cyclophosphamide 1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin 2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide 4-Hydroxy-cyclophosphan-mamophosphatide 50-18-0 60007-95-6 6055-19-2 (monohydrate) 75526-90-8 AC1L1EQQ AI3-26198 ASTA ASTA B518 Anhydrous cyclophosphamide Asta B 518 B 518 B-518 BRN 0011744 BSPBio_002099 Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester C 0768 C07888 C7H15Cl2N2O2P CB 4564 CB-4564 CCRIS 188 CHEBI:4027 CHEMBL32520 CHEMBL88 CID2907 CP CPA CTX CY Ciclofosfamida Ciclofosfamida [INN-Spanish] Ciclofosfamide Ciclophosphamide Ciclophosphamide [INN] Clafen Claphene Cycloblastin Cyclophosphamid Cyclophosphamide Cyclophosphamide (INN) Cyclophosphamide (TN) Cyclophosphamide (anhydrous form) Cyclophosphamide (anhydrous) Cyclophosphamide Monohydrate Cyclophosphamide Sterile Cyclophosphamide anhydrous Cyclophosphamide, (+-)-Isomer Cyclophosphamides Cyclophosphamidum Cyclophosphamidum [INN-Latin] Cyclophosphan Cyclophosphane Cyclophosphanum Cyclophosphoramide Cyclostin Cyklofosfamid Cyklofosfamid [Czech] Cytophosphan Cytophosphane Cytoxan Cytoxan (TN) Cytoxan Lyoph D,L-Cyclophosphamide D07760 | DB00531 DivK1c_000246 EINECS 200-015-4 EU-0100238 Endoxan Endoxan R Endoxan-Asta Endoxana Endoxanal Endoxane Enduxan Genoxal HMS2090A12 HSDB 3047 Hexadrin IDI1_000246 KBio1_000246 KBio2_001338 KBio2_003906 KBio2_006474 KBio3_001319 KBioGR_000888 KBioSS_001338 LS-1302 LS-99787 Ledoxina Lopac-C-0768 Lopac0_000238 Lyophilized Cytoxan Mitoxan MolPort-001-783-420 N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide NCGC00015209-01 NCGC00015209-03 NCGC00015209-06 NCGC00091741-02 NCGC00091741-03 NCI-C04900 NCI60_002097 NINDS_000246 NSC 26271 NSC-26271 NSC26271 NSC273033 NSC273034 Neosar Occupation, cyclophosphamide exposure Procytox RCRA waste no. U058 Rcra Waste Number U058 Rcra waste number U058 Revimmune S1217_Selleck SK 20501 SPBio_001071 STK177249 STOCK2S-91217 Semdoxan Sendoxan Senduxan Spectrum2_001146 Spectrum3_000370 Spectrum4_000304 Spectrum5_000795 Spectrum_000858 UNII-6UXW23996M WLN: T6MPOTJ BO BN2G2G Zyklophosphamid Zyklophosphamid [German] bis(2-Chloroethyl)phosphami de cyclic propanolamide bis(2-Chloroethyl)phosphamide cyclic propanolamide ester cyclophosphamide |
| | 4 | | Ganirelix | approved | Phase 4, Phase 2, Phase 3 | 65 | 123246-29-7, 124904-93-4 | 25081094 | 123246-29-7 124904-93-4 CHEBI:336376 CHEMBL1251 D08010 Ganirelix Ganirelix (INN) Ganirelix [INN:BAN] | Ganirelix acetate Ganirelixum Ganirelixum [INN-Latin] LS-181948 LS-187280 Orgalutran Orgalutran (TN) RS-26306 UNII-IX503L9WN0 | |
| | 5 | | Menotropins | approved | Phase 4 | 61 | 61489-71-2 | 5360545 | 61489-71-2 D02692 Human Menopausal Gonadotrophin Human Menopausal Gonadotrophin (JP15) | Humegon Humegon (TN) LH) MENOTROPINS Menotropins (FSH Menotropins (USP) |
| | 6 | | Cetrorelix | approved, investigational | Phase 4, Phase 2, Phase 3 | 65 | 120287-85-6 | 16129715, 25074887 | 120287-85-6 Ac-D-Nal(2)-D-Phe(pCl)-D-Pal(3)-Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH2 CHEBI:59224 CHEMBL1200490 Cetrorelix Cetrorelix (INN) Cetrorelixum | Cetrorelixum [INN-Latin] Cetrotide (TN) D07665 HS-2008 N-acetyl-3-(2-naphthyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridyl)-D-alanyl-L-seryl-L-tyrosyl-N5-carbomoyl-D-ornithyl-L-leucyl-L-prolyl-D-alaninamide N-acetyl-3-(naphthalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-L-tyrosyl-N(5)-carbamoyl-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide SB 75 SB-75 | |
| | 7 | | Norethindrone | approved | Phase 4, Phase 2, Phase 3 | 96 | 68-22-4 | 6230 | (17-alpha)-17-Hydroxy-19-norpregn-4-en-20-yn-3-one (17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one 17-Ethinyl-19-nor-testosterone 17-Ethinyl-19-nortestosterone 17-Ethynyl-17-hydroxyestr-4-en-3-one 17-Ethynyl-17-hydroxyestr-4-en-3-one (ACD/Name 4.0) 17-Ethynyl-17beta-hydroxyestr-4-en-3-one 17-Ethynyl-19-Nortestosterone 17-Hydroxy-(17alpha)-19-Norpregn-4-en-20-yn-3-one 17-Hydroxy-17-alpha-19-Norpregn-4-en-20-yn-3-one 17-Hydroxy-17-alpha-19-norpregn-4-en-20-yn-3-one 17-Hydroxy-19-Nor-17alpha-pregn-4-en-20-yn-3-one 17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one 17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one 17-alpha-Ethynyl-17-beta-hydroxy-4-estren-3-one 17-alpha-Ethynyl-17-hydroxy-4-estren-3-one 17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one 17-alpha-Ethynyl-19-nortestosterone 17-alpha-Ethynyl-4-estren-17-ol-3-one 17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one 17-ethynyl-17beta-hydroxyestr-4-en-3-one 17.alpha.-Ethinyl-19-nortestosterone 17.alpha.-Ethynyl-19-nortestosterone 17.alpha.-Ethynyl-4-estren-17-ol-3-one 17alpha-Ethinyl-17alpha-Ethinyl-19-nortestosterone 17alpha-Ethinyl-19-Nortestosterone 17alpha-Ethinyl-19-nortestosterone 17alpha-Ethinylestra-4-en-17beta-ol-3-one 17alpha-Ethynyl-17-hydroxy-4-estren-3-one 17alpha-Ethynyl-17-hydroxyest-4-en-3-one 17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one 17alpha-Ethynyl-17beta-hydroxyestr-4-en-3-one 17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one 17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one 17alpha-Ethynyl-19-nortestosterone 17alpha-Ethynyl-3-oxo-4-estren-17beta-ol 17alpha-Ethynyl-4-estren-17-ol-3-one 17alpha-ethynyl-17-hydroxy-Estr-4-en-3-one 17alpha-ethynyl-17beta-hydroxy-19-Norandrost-4-en-3-one 17alpha-pregn-4-en-20-yn-3-one 17beta-Hydroxy-17alpha-ethynylestr-4-en-3-one 17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one 17α-ethinyl-19-nortestosterone 19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one 19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one 19-Nor-17-alpha-ethynyltestosterone 19-Nor-17-ethinyl testosterone 19-Nor-17-ethinyltestosterone 19-Nor-17.alpha.-ethynyltestosterone 19-Nor-17alpa-ethynyltestosterone 19-Nor-17alpha-Ethynyl-17beta-hydroxy-4-androsten-3-one 19-Nor-17alpha-Ethynylandrosten-17beta-ol-3-one 19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one 19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one 19-Nor-17alpha-ethynyltestosterone 19-Nor-ethindrone 19-Nor-ethinyl--4,5-testosterone 19-Norethindrone 19-Norethinyltestosterone 19-Norethisterone 19-nor-17α-ethynyltestosterone 4-Estren-17alpha-ethynyl-17beta-ol-3-one 46525_FLUKA 46525_RIEDEL 68-22-4 A3564/0151191 AC-11100 AC1L1IDS AC1L1M2R AC1NWAOX AC1O5EOU AC1Q6OG5 AI3-26422 AKOS004119895 AR-1C1071 ARONIS24281 Activella Anhydrohydroxynorprogesterone Anovulatorio Anovule BB_NC-0600 BPBio1_000074 BRD-A39415247-001-02-1 BRD-K92073408-001-03-3 BRN 1915671 BSPBio_000066 BSPBio_002101 Brevicon Brevinor Brevinor 21 Brevinor 28 Brevinor-1 21 Brevinor-1 28 C05028 CCRIS 484 CHEBI:7627 CHEMBL1162 CID4536 CID5702093 CID6230 CID6432649 CPD000499579 Camila Camila (TN) Ciclovulan Conceplan Conludaf Conludag D00182 DB00717 Demulen DivK1c_000553 EINECS 200-681-6 ENT Errin Estrinor Ethinyl-19-nortestosterone Ethinylnortestosterone Ethynylmortestosterone Ethynylnortestosterone Gencept Genora Gestest HMS1568D08 HMS1920B10 HMS2090D21 HMS2091J10 HMS501L15 HSDB 3370 I06-0104 | IDI1_000553 Jenest Jenest-28 KBio1_000553 KBio2_001491 KBio2_004059 KBio2_006627 KBio3_001601 KBioGR_000637 KBioSS_001491 LMST02030097 LS-97425 Loestrin MLS001076679 MLS001163874 MLS001304093 Menzol Microneth Micronett Micronor Micronor (TN) Micronovum Milli Mini-Pe Mini-pill Minovlar MolPort-002-507-131 MolPort-002-509-542 MolPort-002-728-977 MolPort-003-861-444 N.E.E N.E.E. N0449 N4128_SIGMA NCGC00178820-01 NCGC00179669-01 NET NINDS_000553 NSC-9564 NSC9564 Nelova Nodiol Nor-Q.D Nor-Q.D. Nor-QD Nora-BE Noraethisteronum Noralutin Norcept Norcept-E Norcolut Norcolute Noresthisterone Norethadrone Norethin Norethin 1/35 E Norethin 1/50 M Norethindirone Norethindrone Norethindrone (USP) Norethindrone Norethisterone Norethindrone [USAN] Norethisteron Norethisterone Norethisterone (JP15) Norethisterone [Progestins] Norethisteronum Norethisteronum [INN-Latin] Norethyndron Norethynodron Norethynodrone Noretisterona Noretisterona [INN-Spanish] Noretisterone Noretisterone [DCIT] Norfor Norgestin Noriday Noriday 28 Norlutate Norluten Norlutin Norluton Normapause Norpregneninlone Norpregneninolone Norpregneninotone Oprea1_606355 Orlest Ortho 1 35 Ortho 7 7 7 Ortho-Novum 1 35 Ortho-Novum 1 50 Ortho-Novum 7 7 7 Ovysmen 0.5 35 Ovysmen 1 35 Prestwick0_000253 Prestwick1_000253 Prestwick2_000253 Prestwick3_000253 Prestwick_646 Primolut N Primolut-N Primolut-N (TN) Proluteasi SAM002564223 SC 4640 SMR000499579 SMR000718762 SPBio_001052 SPBio_002285 SPECTRUM1500437 ST094767 STK730956 STOCK1N-04274 Spectrum2_001066 Spectrum3_000521 Spectrum4_000079 Spectrum5_001198 Spectrum_001011 Synphase Synphasic 28 Tri-Norinyl Triella Trinovum 21 UNII-T18F433X4S Utovlan Utovlar WLN: L E5 B666 OV MUTJ E FQ F1UU1 -A&F ZINC03814419 component of Noriday norethindrone |
| | 8 | | Ethinyl Estradiol | approved | Phase 4, Phase 3 | 728 | 57-63-6 | 5991 | 17 alpha-Ethinylestradiol 17 alpha-Ethynylestradiol 17 alpha-Ethynyloestradiol 17 alpha-ethinyestradiol 17-Ethinyl-3,17-estradiol 17-Ethinyl-3,17-oestradiol 17-Ethinylestradiol 17-Ethynylestradiol 17-Ethynylestradiol ram 17-Ethynyloestradiol 17-alpha-Ethinyl-17-beta-estradiol 17-alpha-Ethynyl-17-beta-oestradiol 17-alpha-Ethynylestradiol 17-alpha-Ethynylestradiol-17-beta 17-alpha-ethynyl estradiol 17-ethinyl-3,17-estradiol 17-ethinyl-3,17-oestradiol 17-ethinylestradiol 17.alpha.-Ethinyl-17.beta.-estradiol 17.alpha.-Ethinylestradiol 17.alpha.-Ethynyl-17.beta.-oestradiol 17.alpha.-Ethynylestradiol 17.alpha.-Ethynylestradiol-l7.beta. 17.alpha.-Ethynyloestradiol 17.alpha.-Ethynyloestradiol-17.beta. 17a-Ethinyl-17b-estradiol 17a-Ethinylestradiol 17a-Ethynyl-17b-oestradiol 17a-Ethynylestradiol 17a-Ethynylestradiol-l7b 17a-Ethynyloestradiol 17a-Ethynyloestradiol-17b 17alpha-Ethinyl estradiol 17alpha-Ethinylestradiol 17alpha-Ethinylestradiol-17beta 17alpha-Ethynylestradiol 17alpha-Ethynyloestradiol 17alpha-Ethynyloestradiol-17beta 17α-ethynylestradiol 406932-93-2 46263_FLUKA 46263_RIEDEL 57-63-6 77538-56-8 AC-2169 AC1L1LK6 AI3-52941 Aethinyloestradiolum Aethinyoestradiol Aethinyoestradiol [German] Alora Amenoron Amenorone Anovlar BIDD:ER0162 BRN 2419975 Bio-0610 C07534 CCRIS 286 CHEBI:4903 CHEMBL691 CID5991 CPD000058319 Certostat Chee-O-Gen Chee-O-Genf Cyclosa D004997 D00554 DB00977 Dicromil Diognat-E Diogyn E Diogyn-E Diprol Dyloform E4876_SIGMA EE EE(sub 2) EE2 EINECS 200-342-2 EO ETHINYLESTRADIOL Effik Brand of Ethinyl Estradiol Ertonyl Esclim Esteed Estigyn Estinyl Estinyl (TN) Eston-E Estopherol Estoral Estoral (Orion) Estoral (VAN) Estoral [Orion] Estoral {[Orion]} Estorals Estradiol, Ethinyl Estradiol, Ethynyl Estring Estrogen Ethidol Ethinoral Ethinyl E2 Ethinyl Estradiol Hemihydrate Ethinyl Estradiol [USP] | Ethinyl Estradiol, (8 alpha)-Isomer Ethinyl Oestradiol Effik Ethinyl estradiol Ethinyl estradiol (USP) Ethinyl-Oestradiol Effik Ethinyl-Oestranol Ethinyl-oestranol Ethinylestradiol Ethinylestradiol (JP15/INN) Ethinylestradiol Jenapharm Ethinylestradiol [INN:BAN:JAN] Ethinylestradiolum Ethinylestradiolum [INN-Latin] Ethinylestriol Ethinyloestradiol Ethinyloestradiol [Steroidal oestrogens] Ethy 11 Ethynyl estradiol Ethynylestradiol Ethynylestradiol, Ethinyl Estradiol Ethynyloestradiol Eticyclin Eticyclol Eticylol Etinestrol Etinestryl Etinilestradiol Etinilestradiol [INN-Spanish] Etinilestradiolo Etinilestradiolo [DCIT] Etinoestryl Etistradiol Etivex Evra Feminone Fempatch Follicoral Ginestrene Gynodiol Gynolett HMS2051I19 HSDB 3587 Halodrin Hemihydrate, Ethinyl Estradiol Inestra Innofem Jenapharm Brand of Ethinyl Estradiol Jenapharm, Ethinylestradiol Kolpolyn LMST02010036 LS-231 Linoral Lynoral MLS000028479 MLS000758274 Marvelon Menolyn Menostar Mercilon Microfollin Microfollin Forte MolPort-001-794-636 NCGC00091533-01 NCGC00091533-04 NCGC00091533-05 NCI60_000234 NSC-10973 NSC10973 Neo-Estrone Nogest-S Novestrol OVULEN-21 OVULEN-28 Oradiol Orestralyn Orestrayln Organon Brand of Ethinyl Estradiol Ortho-Cyclen Ovex Oviol PUBERTAL ETHINYL ESTRADIOL STUDY Palonyl Perovex Primogyn Primogyn C Primogyn M Progynon C Progynon M Prosexol S1625_Selleck SAM001247008 SGCUT00127 SMR000058319 Schering Brand of Ethinyl Estradiol Spanestrin Thiuram E Thiuranide UNII-423D2T571U Vagifem Varnoline WLN: L E5 B666TTT&J E1 FQ F1UU1 OQ Ylestrol component of Demulen component of Oracon component of Ortrel ethinyl estradiol ethynyl estradiol to_000048 | |
| | 9 | | Leuprolide | approved, investigational | Phase 4, Phase 2 | 299 | 53714-56-0 | 3911, 657181 | (D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone 5-oxoPro-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-ProNHC2H5 dihydrate 5-oxoprolylhistidyltryptophylseryltyrosylleucylleucyl-n5-(diaminomethylidene)ornithyl-n-ethylprolinamide AC1L1GZK AC1L9B44 AC1Q5OPO AR-1G9354 C07612 CID3911 CID441410 D00989 D08113 Enantone Enantone (TN) I04-0109 L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide L001094 | L002030 Leuprolide Leuprolide acetate Leuprolide acetate (USAN) Leuprorelin Leuprorelin (INN) Leuprorelin acetate (JAN) Leuprorelina Leuproreline Leuprorelinum Lupron (TN) N-[1-[[1-[[1-[[1-[[1-[[1-[[5-(diaminomethylideneamino)-1-[2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide NSC377526 NSC746847 PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-NHC2H5 PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-nhet acetic acid leuprolide | |
| | 10 | | Estradiol | approved, investigational, vet_approved | Phase 4, Phase 3, Phase 2, Early Phase 1 | 1318 | 50-28-2 | 5757, 53477783 | (+)-3,17b-Estradiol (17b)-Estra-1,3,5(10)-triene-3,17-diol (17beta)-Estra-1,3,5(10)-triene-3,17-diol .alpha.-Estradiol .alpha.-Oestradiol .beta.-Estradiol .beta.-Oestradiol 1,3,5[10]-Estratriene-3,17beta-diol 3-sulfate 1,3,5[10]-Estratriene-3,17beta-diol 3-sulphate 13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol 17 beta-Estradiol 17-.BETA.-Estradiol 17-E 17-beta 17-beta-OH-estradiol 17-beta-estradiol 17.beta.-Estradiol 17.beta.-Oestradiol 17E 17b-Estradiol 17b-Oestradiol 17beta Oestradiol 17beta oestradiol 17beta-Estra-1,3,5(10)-triene-3,17-diol 17beta-Estradiol 17beta-Oestradiol 1jgl 1qkt 1qku 2d06 3,17-Epidihydroxyestratriene 3,17-beta-Estradiol 3,17-beta-Oestradiol 3,17.beta.-Estradiol 3,17b-Dihydroxyestra-1,3,5(10)-triene 3,17b-Estradiol 3,17beta-Estradiol 3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulfate 3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulphate 50-28-2 73459-61-7 873662-39-6 AC-10460 AC1L1L2K Aerodiol Agofollin Alora Altrad Amnestrogen Aquadiol B-Estradiol BEDOs BIDD:ER0125 BIDD:PXR0065 BPBio1_000532 BSPBio_000482 BSPBio_001065 Bardiol Benzhormovarine Beta-estradiol Bio-0812 Bio-E-Gel Bio1_000403 Bio1_000892 Bio1_001381 Bio2_000363 Bio2_000843 C00951 C18H24O2 CCRIS 280 CHEBI:16469 CHEMBL135 CID5757 CMC_11154 CPD-352 CPD000059126 Climaderm Climara Climara (TN) Climara Forte Compudose Compudose 200 Compudose 365 Corpagen D-3,17beta-Estradiol D-Estradiol D-Oestradiol D00105 DB00783 Dermestril Destradiol Dihydro-Theelin Dihydrofollicular hormone Dihydrofolliculin Dihydromenformon Dihydrotheelin Dihydroxyesterin Dihydroxyestrin Dihydroxyoestrin Dimenformon Diogyn Diogynets Divigel Divigel (TN) E 2 E 8875 E(sub 2) E0025 E1024_SIGMA E1132_SIGMA E2257_SIGMA E2758_SIGMA E8875_SIGMA EINECS 200-023-8 EU-0100503 Elestrin Encore Epiestriol 50 Esclim Estra-1,3,5(10)-triene-3,17b-diol Estrace Estrace (TN) Estraderm Estraderm (TN) Estraderm MX Estraderm TTS Estraderm TTS 100 Estraderm TTS 50 Estradiol Estradiol [USAN:INN] Estradiol-17 beta Estradiol-17-beta Estradiol-17.beta. Estradiol-17beta Estradiol-3,17beta Estradiolo Estradiolo [DCIT] Estradiolum Estradiolum [INN] Estradot Estraldine Estrapak 50 Estrasorb Estrasorb (TN) Estreva Estrifam Estring Estring (TN) Estring Vaginal Ring Estring vaginal ring Estroclim Estroclim 50 Estrodiolum Estrofem 2 Estrofem Forte Estrogel | Estrogel (TN) Estrogel HBF Estrovite Evamist Evorel Extrasorb Femanest Femestral Femestrol Femogen Fempatch Femtrace Femtran Follicyclin Gelestra Ginedisc Ginosedol GynPolar Gynergon Gynestrel Gynodiol Gynoestryl HMS1362E07 HMS1569I04 HMS1792E07 HMS1990E07 HMS2051C17 HMS2090E18 HSDB 3589 IDI1_002118 Innofem Innofem (TN) KBio2_000405 KBio2_002269 KBio2_002973 KBio2_004837 KBio2_005541 KBio2_007405 KBio3_000769 KBio3_000770 KBio3_002749 KBioGR_000405 KBioGR_002269 KBioSS_000405 KBioSS_002270 LMST02010001 LS-137 Lamdiol Lio-Oid Lopac0_000503 MLS000069494 MLS000758312 MLS001076331 Macrodiol Macrol Menest Menorest Menostar Microdiol MolPort-001-794-632 NCGC00091544-00 NCGC00091544-01 NCGC00091544-02 NCGC00091544-04 NCGC00091544-05 NCGC00091544-06 NCGC00091544-07 NCGC00091544-08 NCGC00091544-09 NCGC00091544-12 NCGC00179321-01 NCGC00179321-02 NSC-9895 NSC9895 Nordicol Oesclim Oestergon Oestra-1,3,5(10)-triene-3,17b-diol Oestradiol Oestradiol Berco Oestradiol R Oestradiol-17-beta Oestradiol-17.beta. Oestradiol-17beta Oestradiolum Oestrogel Oestroglandol Oestrogynal Ovahormon Ovasterol Ovastevol Ovociclina Ovocyclin Ovocycline Ovocylin Perlatanol Polyestradiol Prestwick0_000441 Prestwick1_000441 Prestwick2_000441 Prestwick3_000441 Prestwick_207 Primofol Profoliol Profoliol B Progynon Progynon DH Progynon-DH S-21400 S1709_Selleck SAM001247032 SK-Estrogens SL-1100 SMP1_000121 SMR000059126 SPBio_002421 Sandrena 1 Sandrena Gel Sisare Gel Spectrum5_002055 Syndiol Systen Tradelia Trial SAT Trocosone UNII-4TI98Z838E VIVELLE-DOT Vagifem Vagifem (TN) Vivelle Vivelle (TN) Zerella Zesteem Zesteen Zumenon [2,4,6,7-3H]-E2 [3H]-estradiol [3H]]estradiol b-Estradiol beta-Estradiol beta-Estradiol 3-sulfate beta-Estradiol 3-sulphate bmse000642 cMAP_000005 cis-Estradiol cis-Oestradiol component of Menrium delta-Estradiol delta-Oestradiol estradiol estradiol-17beta nchembio.168-comp3 nchembio.76-comp2 nchembio775-comp2 nchembio794-comp6 nchembio860-comp1 progynon | |
| | 11 | | Lenograstim | approved | Phase 4 | 1220 | 135968-09-1 | | G-CSF (CHO cell derived) Glycosylated recombinant G-CSF Glycosylated recombinant granulocyte colony stimulating factor | Granulocyte colony stimulating factor 3 (CHO cell derived) Granulocyte colony-stimulating factor lenograstim Lenograstim (genetical recombination) Lenograstim rDNA | |
| | 12 | | Doxil | Approved June 1999 | Phase 4, Phase 3 | 1751 | | 31703 | | Evacet LipoDox Pegylated Liposomal Doxorubicin Hydrochloride liposomal doxorubicin |
| | 13 | | Hormones, Hormone Substitutes, and Hormone Antagonists | | Phase 4, Phase 3, Phase 2, Phase 1 | 13168 | | | | 14 | | Hormones | | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 14415 | | | | 15 | | Follicle Stimulating Hormone | | Phase 4, Phase 1, Phase 2, Early Phase 1 | 167 | | | | 16 | | Anti-Bacterial Agents | | Phase 4, Phase 3 | 11226 | | | | 17 | | Hormone Antagonists | | Phase 4, Phase 3, Phase 2, Phase 1 | 13180 | | | | 18 | | Antibiotics, Antitubercular | | Phase 4, Phase 3 | 7180 | | | | 19 | | Antineoplastic Agents, Alkylating | | Phase 4, Phase 3, Phase 2 | 4603 | | | | 20 | | Topoisomerase Inhibitors | | Phase 4, Phase 3 | 5069 | | | | 21 | | Alkylating Agents | | Phase 4, Phase 3, Phase 2 | 4827 | | | | 22 | | Immunosuppressive Agents | | Phase 4, Phase 3, Phase 2 | 13086 | | | | 23 | | Estrogens | | Phase 4, Phase 3, Phase 2, Early Phase 1 | 2542 | | | | 24 | | Antirheumatic Agents | | Phase 4, Phase 3, Phase 2 | 10956 | | | | 25 | | Deslorelin | | Phase 4, Phase 2, Phase 3 | 176 | | | | 26 | | Antineoplastic Agents, Hormonal | | Phase 4, Phase 3, Phase 2 | 5592 | | | | 27 | | s 1 (combination) | | Phase 4 | 378 | | | Gimeracil / oteracil / tegafur TS 1 | |
| | 28 | | Fertility Agents | | Phase 4, Phase 2 | 505 | | | | 29 | | Triptorelin Pamoate | | Phase 4, Phase 3, Phase 2 | 169 | | | | 30 | | Luteolytic Agents | | Phase 4, Phase 3, Phase 2 | 306 | | | | 31 | | Polyestradiol phosphate | | Phase 4, Phase 3, Phase 2, Early Phase 1 | 1318 | | | | 32 | | Estradiol 3-benzoate | | Phase 4, Phase 3, Phase 2, Early Phase 1 | 1318 | | | | 33 | | Estradiol valerate | | Phase 4, Phase 3, Phase 2, Early Phase 1 | 1318 | 979-32-8 | | | 34 | | Chorionic Gonadotropin | | Phase 4 | 196 | | | | 35 | | Contraceptives, Oral | | Phase 4, Phase 2, Phase 3 | 1327 | | | | 36 | | Contraceptive Agents | | Phase 4, Phase 3, Phase 2 | 1967 | | | | 37 | | Lactitol | | Phase 4 | 336 | 585-86-4 | 3871 | 4-O-b-D-Galactopyranosyl-D-glucitol, 9CI E966 Emportal | Floralac Importal Oponaf Portolac | |
| | 38 | | Estradiol 17 beta-cypionate | | Phase 4, Phase 3, Phase 2, Early Phase 1 | 1318 | | | | 39 | | Norinyl | | Phase 4 | 38 | | | | 40 | | Norethindrone acetate | | Phase 4, Phase 2, Phase 3 | 96 | | | | 41 | | Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination | | Phase 4 | 38 | | | | 42 | | Progestins | | Phase 4, Phase 3, Phase 2, Early Phase 1 | 564 | | | | 43 | | Adjuvants, Immunologic | | Phase 4, Phase 2, Phase 3, Early Phase 1 | 2554 | | | | 44 | | Dacarbazine | approved, investigational | Phase 3 | 688 | 4342-03-4 | 5351166 | (5E)-5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide (5Z)-5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide (Dimethyltriazeno)imidazolecarboxamide 37626-23-6 4(5)-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide 4(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide 4-(3,3-Dimethyl-1-triazeno)imidazole-5-carboxamide 4-(3,3-Dimethyltriazeno)imidazole-5-carboxamide 4-(5)-(3,3-Dimethyl-1-triazeno)imidazole-5(4)-carboxamide 4-(Dimethyltriazeno)imidazole-5-c arboxamide 4-(Dimethyltriazeno)imidazole-5-carboxamide 4-(or 5)-(3,3-Dimethyl-1-triazeno)imidazole-5(or 4)-carboxamide 4-(or 5)-(3,3-Dimethyl-1-triazeno)imidazole-5(or 4)-carboxamide 4-[(1E)-3,3-Dimethyltriaz-1-en-1-yl]-1H-imidazole-5-carboxamide 4-[3,3-dimethyltriaz-1-en-1-yl]-1H-imidazole-5-carboxamide 4342-03-4 5(or 4)-(dimethyltriazeno)imidazol e-4(or 5)-carboxamide 5(or 4)-(dimethyltriazeno)imidazole-4(or 5)-carboxamide 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide 5-(3,3-Dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide 5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide 5-(3,3-Dimethyltri azeno)imidazole-4-carboxamide 5-(3,3-Dimethyltriazeno)-imidazole-4-carbamide 5-(3,3-Dimethyltriazeno)imidazole-4-carboxamide 5-(3,3-dimethyltriaz-1-en-1-yl)-1H-imidazole-4-carboxamide 5-(Dimethyltriazeno)-4-imidazolecarboxamide 5-(Dimethyltriazeno)imidazole-4-carboxamide 5-(Dimethyltriazeno)imidazole-4-carboximide 5-(dimethylaminohydrazinylidene)imidazole-4-carboxamide 5-[3,3-Dimethyl-1-triazenyl]imidazole-4-carboxamide 94361-71-4 AC1NQXVV AC1NS01W AC1NS4BN AI3-52825 BPBio1_000428 BRD-K35520305-001-07-8 BSPBio_000388 BSPBio_002091 Biocarbazin Biocarbazine Biocarbazine R C6H10N6O CAS-891986 CCRIS 190 CHEBI:4305 CHEMBL476 CID5281007 CID5351166 CID5353562 Carboxamide, Dimethyl Imidazole D00288 D003606 D2390_SIGMA D3634 DB00851 DIC DTCI DTIC DTIC Dome DTIC, DTIC-Dome, Dacarbazine DTIC-Dome DTICDome DTIE Dacarbazin Dacarbazina Dacarbazine Dacarbazine (JAN/USP/INN) Dacarbazine [USAN:INN:BAN:JAN] Dacarbazino Dacarbazino [INN-Spanish] Dacarbazinum Dacarbazinum [INN-Latin] | Dacatic Decarbazine Deticene Di-me-triazenoimidazolecarboxamide Di-methyl-triazenoimidazolecarboxamide Dimethyl Imidazole Carboxamide Dimethyl Triazeno Imidazole Carboxamide Dimethyltriazenoimidazolecarboxamide DivK1c_000326 Dtic-Dome Dtic-Dome (TN) Dtic-dome (tn) EINECS 224-396-1 HE1150000 HMS1569D10 HMS2090A20 HMS2091I20 HMS501A08 HSDB 3219 I06-2280 I14-1659 ICDMT ICDT IDI1_000326 Imidazole Carboxamide Imidazole Carboxamide, Dimethyl Imidazole carboxamide KBio1_000326 KBio2_001364 KBio2_003932 KBio2_006500 KBio3_001311 KBioGR_000896 KBioSS_001364 LS-119 MLS001332543 MLS001332544 MolPort-003-666-153 MolPort-003-846-120 MolPort-006-709-420 NCGC00016986-01 NCGC00091861-01 NCGC00091861-02 NCGC00091861-03 NCGC00091861-04 NCI-C04717 NCI60_004053 NCIMech_000261 NINDS_000326 NIOSH/HE1150000 NPFAPI-05 NSC 45388 NSC-45388 NSC45388 Prestwick0_000574 Prestwick1_000574 Prestwick2_000574 Prestwick3_000574 Prestwick_904 S1221_Selleck SMP2_000251 SMR000857131 SPBio_001075 SPBio_002607 SPECTRUM1500218 ST51014976 Spectrum2_001148 Spectrum3_000366 Spectrum4_000308 Spectrum5_000823 Spectrum_000884 UNII-7GR28W0FJI WLN: T5M CNJ DVZ ENUNN1&1 dacarbazine | |
| | 45 | | Paclitaxel | approved, vet_approved | Phase 3 | 2864 | 33069-62-4 | 36314 | (2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester 12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine 157069-30-2 33069-62-4 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv. 7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv. 7-Epi-Paclitaxel 7-Epi-Taxol 7-Epipaclitaxel 7-Epitaxol 7-epi-Paclitaxel 7-epi-Taxol AB00513812 ABI 007 ABI-007 ABI007 AC-675 AC1L1IOG AC1L1VJI AC1L9AVF ACon1_002231 ANX-513 Abraxane Abraxane (TN) Abraxane I.V. Suspension Abraxis BioScience brand of albumin-bound paclitaxel Ambotz33069-62-4 Anzatax Asotax BIDD:PXR0046 BMS 181339-01 BMS-181339 BMS-181339-01 BPBio1_000320 BRD-A23723433-001-01-2 BRD-A28746609-001-04-0 BRD-K62008436-001-03-1 BSPBio_000290 BSPBio_001152 BSPBio_002614 Bio-0076 Bio1_000362 Bio1_000851 Bio1_001340 Bio2_000416 Bio2_000896 Bristaxol C07394 C466458 C47H51NO14 CCRIS 8143 CHEBI:103439 CHEBI:45863 CHEMBL100910 CHEMBL418410 CHEMBL48 CID36314 CID441276 CID4666 CID6713921 CID6915727 CPD-8718 Capxol D00491 DB01229 DHP-107 DHP-208 DRG-0190 DTS-301 DivK1c_000441 EU-0101201 Ebetaxel EmPAC Epitaxol Genaxol Genetaxyl Genexol Genexol-PM HMS1362J13 HMS1568O12 HMS1792J13 HMS1922K08 HMS1990J13 HMS2090D07 HMS2093K15 HMS501G03 HSDB 6839 I06-0014 IDI1_000441 IDI1_002171 Intaxel KBio1_000441 KBio2_000492 KBio2_002016 KBio2_002509 KBio2_003060 KBio2_004584 KBio2_005077 KBio2_005628 KBio2_007152 KBio2_007645 KBio3_000903 KBio3_000904 KBio3_001834 KBio3_002987 KBioGR_000492 KBioGR_001893 | KBioGR_002509 KBioSS_000492 KBioSS_002016 KBioSS_002517 LMPR0104390001 LS-31070 LipoPac Lopac0_001201 MBT 0206 MEGxp0_001940 MLS000863266 MLS001077297 MLS002154218 MLS002172439 MLS002695976 MPI-5018 Micellar Paclitaxel Mitotax MolPort-001-742-627 MolPort-003-665-783 MolPort-003-932-365 NCGC00024995-02 NCGC00024995-03 NCGC00024995-04 NCGC00024995-05 NCGC00024995-06 NCGC00024995-07 NCGC00164367-01 NCGC00164367-02 NCGC00164367-03 NCI60_000601 NINDS_000441 NK 105 NP-010981 NSC 125973 NSC-125973 NSC125973 NSC358882 Nanotaxel Neuro_000060 Nova-12005 OAS-PAC-100 OncoGel Onxal Onxol Onxol, Taxol, Nov-Onxol, Paclitaxel P1632 Paclical Pacligel Paclitaxel Paclitaxel (JAN/USP) Paclitaxel (JAN/USP/INN) Paclitaxel (Taxol) Paclitaxel [USAN:INN:BAN] Paxceed Paxene Paxoral Plaxicel Praxel Prestwick0_000155 Prestwick1_000155 Prestwick2_000155 Prestwick3_000155 Probes2_000350 QW 8184 S-8184 Paclitaxel Injectable Emulsion S1150_Selleck SDCCGMLS-0066823.P001 SDP-013 SMP1_000228 SMR000394086 SMR000857385 SPBio_000943 SPBio_002229 SPECTRUM1503908 ST50306996 Spectrum2_000872 Spectrum3_001057 Spectrum4_001197 Spectrum5_001491 Spectrum_001536 T 7402 T1912_SIGMA T7191_SIGMA T7402_SIGMA TA1 TAXOL (TN) TAXOL, 10-EPI, TXL TaxAlbin Taxol Taxol A Taxol Konzentrat Taxol.RTM. (Registered Trademark) UNII-P88XT4IS4D UPCMLD-DP108:001 UPCMLD-DP108:002 Vascular Wrap Xorane Yewtaxan abi-007 albumin-bound paclitaxel cMAP_000068 nab-paclitaxel nchembio.188-comp1 nchembio.2007.34-comp9 nchembio.215-comp9 nchembio853-comp6 paclitaxel weekly paclitaxel |
| | 46 | | Methylprednisolone | approved, vet_approved | Phase 3, Phase 2 | 1193 | 83-43-2 | 6741 | (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one (6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione .DELTA.1-6.alpha.-Methylhydrocortisone 1-Dehydro-6alpha-methylhydrocortisone 1-dehydro-6alpha-Methylhydrocortisone 1-dehydro-6α-methylhydrocortisone 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 121673-01-6 4-08-00-03498 (Beilstein Handbook Reference) 46436_FLUKA 46436_RIEDEL 570-35-4 6 Methylprednisolone 6-Methylprednisolone 6-alpha-Methylprednisolone 6.alpha.-Methylprednisolone 6923-42-8 6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 6alpha-Methylprednisolone 6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 83-43-2 AC1L1N7A Artisone-Wyeth Artisone-wyeth BPBio1_000174 BRD-K35240538-001-03-1 BRN 2340300 BSPBio_000158 Besonia Bio-0658 CHEBI:6888 CHEMBL650 CID6741 CPD000058330 D00407 D008775 DB00959 Depo-Medrol (acetate) Dopomedrol EINECS 201-476-4 Esametone Firmacort HMS1568H20 HMS2090B13 HSDB 3127 LMST02030178 LS-118498 Lemod M0639_SIGMA M1665 MEPRDL MLS000028541 MLS001148159 MLS002207191 Medesone Medixon Medlone 21 | Medrate Medrol Medrol (TN) Medrol Adt Pak Medrol Dosepak Medrol adt pak Medrol dosepak Medrol, Solu-Medrol, Medrone, Methylprednisolone Medrone Mesopren Metastab Methyleneprednisolone Methylprednisolon Methylprednisolone Methylprednisolone (JP15/USP/INN) Methylprednisolone [USAN:INN:BAN:JAN] Methylprednisolone, 6-alpha Methylprednisolonum Methylprednisolonum [INN-Latin] Metilbetasone Metilprednisolona Metilprednisolona [INN-Spanish] Metilprednisolone Metilprednisolone [DCIT] Metilprednisolone [Dcit] Metipred Metrisone Metrocort Metysolon Moderin MolPort-002-528-554 NCGC00022735-03 NCI60_001657 NSC-19987 NSC19987 Nirypan Noretona Predni N Tablinen Prednol- L Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI) Prestwick0_000279 Prestwick1_000279 Prestwick2_000279 Prestwick3_000279 Prestwick_622 Promacortine Reactenol S1733_Selleck SAM002589984 SMR000058330 SPBio_002377 Sieropresol Solomet Summicort Suprametil U 7532 UNII-X4W7ZR7023 Urbason Urbasone Wyacort ZINC03875560 delta(1)-6alpha-Methylhydrocortisone delta(sup 1)-6-alpha-Methylhydrocortisone methylprednisolone methylprenisolone |
| | 47 | | Triamcinolone | approved, vet_approved | Phase 3 | 510 | 124-94-7 | 31307 | (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one 11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione 11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione 11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione 11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione 124-94-7 4-08-00-03629 (Beilstein Handbook Reference) 83474-03-7 9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9-alpha-Fluoro-16-alpha-hydroxyprednisolone 9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy 9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d 9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione 9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone 9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9alpha-Fluoro-16alpha-hydroxyprednisolone 9α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 9α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione 9α-fluoro-16α-hydroxyprednisolone AC-2072 AC1L1LDH AC1Q5HJC Adcortyl Aristocort Aristocort A Aristocort Tablets Aristogel Aristospan Azmacort BPBio1_000154 BRD-K77554836-001-03-3 BRN 2341955 BSPBio_000140 Bio-0662 C21H27FO6 CHEMBL1451 CID31307 CL 19823 Celeste Cinolone Cinolone-T D00385 D014221 DB00620 Delphicort EINECS 204-718-7 EU-0101179 Fluoxiprednisolone Fluoxyprednisolone Flutex Fougera HMS1568G22 HMS2090D12 HSDB 3194 Kenacort Kenacort (TN) Kenacort-A Kenacort-AG Kenacort-Ag Kenalog Kenalog in Orabase Kenalog-10 Kenalog-40 Kenalog-H LS-698 Ledercort Lopac0_001179 | MLS000028542 MLS001066543 MLS002695935 MolPort-002-528-981 Mycolog NCGC00021580-03 NCGC00021580-04 NCGC00021580-05 NCGC00021580-06 NCGC00021580-07 NCI60_000750 NSC 13397 NSC13397 Nasacort Nasacort Aq Nasacort Hfa Omcilon Omicilon Oracort Oralone Orion Polcortolon Pregna-1,4-diene-3,20-dio Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha) Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI) Prestwick0_000120 Prestwick1_000120 Prestwick2_000120 Prestwick3_000120 Prestwick_438 Rodinolone S1933_Selleck SK-Triamcinolone SMP1_000300 SMR000058333 SPBio_002079 Sk-Triamcinolone T6376_SIGMA TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7)) Tiamcinolonum Tiamcinolonum [INN-Latin] Tri-Nasal Triacet Triacort Triam-Tablinen Triamcet Triamcinalone Triamcinlon Triamcinolon Triamcinolona Triamcinolona [INN-Spanish] Triamcinolone (JP15/USP/INN) Triamcinolone [USAN:INN:BAN:JAN] Triamcinolone acetonide Triamcinolone diacetate Triamcinolone hexacetonide Triamcinolonum Triamcinolonum [INN] Triatex Tricortale Triderm Trilone Tristoject Trymex UNII-1ZK20VI6TY Vetalog Volon Volon A WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ ZINC03882036 droxypregna-1,4-diene-3,20-dione ione nchembio.2007.53-comp7 triamcinolone | |
| | 48 | | Gabapentin | approved, investigational | Phase 3 | 303 | 60142-96-3 | 3446 | 1-(Aminomethyl)-cyclohexaneacetic acid 1-(Aminomethyl)cyclohexaneacetic acid 2-[1-(aminomethyl)cyclohexyl]acetic acid 60142-96-3 AC-1485 AC1L1FYE AC1Q53PH AKOS000280865 Aclonium Apo-Gabapentin Apotex brand of gabapentin Aventis brand of gabapentin BB_SC-1512 BIDD:GT0656 BPBio1_000993 BRN 2359739 BSPBio_000901 C040029 C9H17NO2 CAS-60142-96-3 CCRIS 7210 CHEBI:188316 CHEBI:42797 CHEMBL940 CI 945 CI-945 CID3446 D00332 DB00996 DDS-2003 DM-1796 DM-5689 EINECS 262-076-3 EU-0100582 G-154 G0318 G154_SIGMA GBN GOE 2450 Gabapen Gabapentin Gabapentin (JAN/USAN/INN) Gabapentin GR Gabapentin Hexal Gabapentin Stada Gabapentin [USAN:INN:BAN] Gabapentin-ratiopharm Gabapentina Gabapentine Gabapentine [INN-French] Gabapentino Gabapentino [INN-Spanish] Gabapentino [Spanish] Gabapentinum | Gabapentinum [INN-Latin] Gabapetin Go 3450 Goe-3450 HMS1570N03 HMS2089J03 HSDB 7364 Hexal brand of gabapentin I06-0677 L000733 LS-7194 Lopac-G-154 Lopac0_000582 MLS000069358 MolPort-000-883-862 NCGC00015466-01 NCGC00015466-02 NCGC00015466-06 NCGC00015466-09 NCGC00016891-01 NCGC00021545-02 NCGC00021545-04 NCGC00021545-05 NSC742194 Neurontin Neurontin (TN) Novo-Gabapentin Novo-Gabapentine Novopharm brand of gabapentin PMS-Gabapentin Parke Davis brand of gabapentin Pfizer brand of gabapentin Pharmascience brand of gabapentin Prestwick0_000861 Prestwick1_000861 Prestwick2_000861 Prestwick3_000861 Prestwick_151 S2133_Selleck SMR000058311 SPBio_002822 STK598009 Serada Stadapharm brand of gabapentin TL8003814 Tocris-0806 UNII-6CW7F3G59X Vultin Warner-Lambert brand of gabapentin [1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID gabapentin gabapentin (Neurontin) gabapentina gabapentinium ratiopharm brand of gabapentin | |
| | 49 | | Procarbazine | approved | Phase 3 | 69 | 671-16-9 | 4915 | 1-Methyl-2-(p-(isopropylcarbamoyl)benzyl)hydrazine 2-(p-Isopropylcarbamoylbenzyl)-1-methylhydrazine 366-70-1 (mono-hydrochloride) 4-((2-Methylhydrazino)methyl)-N-isopropylbenzamide 4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide 671-16-9 AC-4547 AC1L1J8E Ambap671-16-9 BIDD:GT0183 BPBio1_001369 BRN 0958270 BSPBio_001244 Benzamide, N-(1-methylethyl)-4-((2-methylhydrazino)methyl)- (9CI) C07402 C12H19N3O CAS-366-70-1 CB 400-497 CCRIS 2389 CHEMBL1321 CID4915 D08423 DB01168 EINECS 211-582-2 HMS2090J09 HSDB 3250 I01-8931 IBZ Ibenzmethyzin Ibenzmethyzine LS-7671 MBH MIH MolPort-005-940-370 N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamide | N-(1-Methylethyl)-4-[(2-methylhydrazino)methyl]benzamide N-4-Isopropylcarbamoylbenzyl-N'-methylhydrazine N-Isopropyl-4-[(2-methylhydrazino)methyl]benzamide N-Isopropyl-alpha-(2-methylhydrazino)-p-toluamide N-Isopropyl-p-(2-methylhydrazinomethyl)-benzamide N-Isopropyl-α-(2-methylhydrazino)-p-toluamide N-isopropyl-4-[(2-methylhydrazino)methyl]benzamide NCGC00016438-01 NCGC00016438-02 NCI60_041703 NCIOpen2_004074 NSC-77213 Natulan Natulanar PCX Prestwick0_001112 Prestwick1_001112 Prestwick2_001112 Prestwick3_001112 Procarbazin Procarbazin [German] Procarbazina Procarbazina [INN-Spanish] Procarbazine (INN) Procarbazine Monohydrochloride Procarbazine [INN:BAN] Procarbazinum Procarbazinum [INN-Latin] Ro 4-6467 Ro 4-6467/1 SPBio_003112 SRI-10847 UNII-35S93Y190K p-(2-Methylhydrazinomethyl)-N-isopropylbenzamide p-(N'-Methylhydrazinomethyl)-N-isopropylbenzamide procarbazine | |
| | 50 | | Methotrexate | approved | Phase 3 | 1551 | 1959-05-2, 59-05-2 | 126941 | 4-amino-10-methylfolic acid 4-amino-N(10)-methylpteroylglutamic acid Abitrexate Amethopterin Amethopterine Antifolan Arbitrexate Emtexate Folex HDMTX L-Amethopterin Ledertrexate MTX Metatrexan | Methopterin Methotextrate Methotrate Methotrexat Methotrexate Sodium Methotrexatum Methylaminopterin Methylaminopterinum Metotrexato Mexate Méthotrexate N-Bismethylpteroylglutamic Acid N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid Rheumatrex Trexall | |
|
Interventional clinical trials: (show top 50)
(show all 102)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Effects of ADSC Therapy in Women With POF | Unknown status | NCT01853501 | Phase 4 | | 2 | Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer | Unknown status | NCT00352872 | Phase 4 | | 3 | Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian Failure | Completed | NCT00732693 | Phase 4 | | 4 | Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response and High Basal FSH | Completed | NCT00417157 | Phase 4 | | 5 | Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders | Completed | NCT00417066 | Phase 4 | | 6 | Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism | Completed | NCT00837616 | Phase 4 | | 7 | A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation | Completed | NCT00298025 | Phase 4 | | 8 | Randomized Controlled Trial Comparing Embryonic Quality in rFSH Versus hMG in IVF Protocol With GnRH Antagonist | Completed | NCT02412904 | Phase 4 | | 9 | Filgrastim for Premature Ovarian Insufficiency | Active, not recruiting | NCT02783937 | Phase 4 | | 10 | Effect of Cetrorelex Acetate on Ovarian Function in Women Undergoing Chemotherapy | Withdrawn | NCT00507780 | Phase 4 | | 11 | Cognitive Behavioral Therapy (CBT) and Physical Exercise for Climacteric Symptoms in Breast Cancer Patients Experiencing Treatment-Induced Menopause: a Multicenter Randomized Trial | Unknown status | NCT00582244 | Phase 3 | | 12 | Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer | Completed | NCT00427245 | Phase 3 | | 13 | Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery | Completed | NCT00311636 | Phase 3 | | 14 | Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure | Completed | NCT01160315 | Phase 2, Phase 3 | | 15 | S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer | Completed | NCT00068601 | Phase 3 | | 16 | Estrogen Treatment (Oral vs. Patches) in Turner Syndrome | Completed | NCT00140998 | Phase 3 | | 17 | Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer | Completed | NCT01530607 | Phase 3 | | 18 | Pilot Study Comparing Hypnotherapy and Gabapentin for Hot Flashes. | Completed | NCT00711529 | Phase 3 | | 19 | Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma | Completed | NCT00433459 | Phase 3 | | 20 | Endometrial Injury and IVF Outcome Parameters in Patients With Failed IVF Cycles | Completed | NCT01798862 | Phase 2, Phase 3 | | 21 | Hormone Replacement for Premature Ovarian Insufficiency | Recruiting | NCT02922348 | Phase 3 | | 22 | Dehydroepiandrosterone (DHEA) Treatment and Premature Ovarian Failure (POF) | Terminated | NCT00948857 | Phase 2, Phase 3 | | 23 | Effect of Exercise and Phytoestrogen on Bone, Metabolic Syndrome Criteria and Complaints of the Early Menopause | Terminated | NCT00663104 | Phase 3 | | 24 | Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer | Terminated | NCT00429403 | Phase 3 | | 25 | Stem Cell Therapy Combined Hormone Replacement Therapy in Patients With Premature Ovarian Failure | Unknown status | NCT01742533 | Phase 1, Phase 2 | | 26 | Autologous Mesenchymal Stem Cells Transplantation In Women With Premature Ovarian Failure | Unknown status | NCT02062931 | Phase 1, Phase 2 | | 27 | Autologous Stem Cells Transplantation in Patients With Idiopathic and Drug Induced Premature Ovarian Failure | Unknown status | NCT02043743 | Phase 1, Phase 2 | | 28 | Pregnancy After Stem Cell Transplantation in Premature Ovarian Failure | Completed | NCT02151890 | Phase 1, Phase 2 | | 29 | Hormone Replacement in Young Women With Premature Ovarian Failure | Completed | NCT00001951 | Phase 2 | | 30 | "It is a Real" The First Baby Of Autologous Stem Cell Therapy in Premature Ovarian Failure | Completed | NCT02372474 | Phase 1, Phase 2 | | 31 | Bioidentical 'Natural' Hormone Evaluation in Early Menopause | Completed | NCT00302731 | Phase 2 | | 32 | GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients | Completed | NCT00429494 | Phase 2 | | 33 | Red Blood Cell (RBC) Survival Following Transfusion in Infants | Completed | NCT00731588 | Phase 2 | | 34 | Autologous Adipose Derived Mesenchymal Stromal Cells Transplantation in Women With Premature Ovarian Failure (POF) | Recruiting | NCT02603744 | Phase 1, Phase 2 | | 35 | Transplantation of HUC-MSCs With Injectable Collagen Scaffold for POF | Recruiting | NCT02644447 | Phase 1, Phase 2 | | 36 | Project 1, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Childbearing Age Women | Recruiting | NCT02250534 | Phase 1, Phase 2 | | 37 | Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Premature Ovarian Failure (POF) | Active, not recruiting | NCT03069209 | Phase 1, Phase 2 | | 38 | Rituximab and Belimumab for Lupus Nephritis | Active, not recruiting | NCT02260934 | Phase 2 | | 39 | Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF | Enrolling by invitation | NCT02179255 | Phase 1, Phase 2 | | 40 | Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure | Terminated | NCT00555477 | Phase 2 | | 41 | Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients | Terminated | NCT01551368 | Phase 2 | | 42 | Effects of an Estrogen Replacement Therapy Skin Patch on Ovulation in Women With Premature Ovarian Failure | Withdrawn | NCT00370019 | Phase 2 | | 43 | The Role of Vitamin D in Menopause: Relationship to Menopausal Symptoms in Body Composition | Completed | NCT01141972 | Phase 1 | | 44 | A Therapeutic Trial of Human Amniotic Epithelial Cells Transplantation for Primary Ovarian Insufficiency Patients | Recruiting | NCT02912104 | Phase 1 | | 45 | Inovium Ovarian Rejuvenation Trials | Not yet recruiting | NCT03178695 | Phase 1 | | 46 | Premature Ovarian Failure (Genetic and Physiopathologic Analysis) | Unknown status | NCT00780897 | | | 47 | Inactive FSH in Galactosemia | Unknown status | NCT00619333 | | | 48 | Perception and Attitude Toward Estrogen Therapy Among Surgically Menopausal Women | Unknown status | NCT00173550 | | | 49 | In Vitro Activation of Dormant Follicles for Patients With Primary Ovarian Insufficiency | Unknown status | NCT02322060 | | | 50 | 'SPRING'-Study: "Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists" | Unknown status | NCT00119925 | |
Inferred drug relations via UMLS68/NDF-RT46: Show with subtypes
|
